These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 29088842)
1. 2'-Hydroxyflavanone: A novel strategy for targeting breast cancer. Singhal J; Nagaprashantha L; Chikara S; Awasthi S; Horne D; Singhal SS Oncotarget; 2017 Sep; 8(43):75025-75037. PubMed ID: 29088842 [TBL] [Abstract][Full Text] [Related]
2. 2'-Hydroxyflavanone inhibits in vitro and in vivo growth of breast cancer cells by targeting RLIP76. Singhal J; Chikara S; Horne D; Salgia R; Awasthi S; Singhal SS Mol Carcinog; 2018 Dec; 57(12):1751-1762. PubMed ID: 30136444 [TBL] [Abstract][Full Text] [Related]
3. 2'-hydroxyflavanone inhibits proliferation, tumor vascularization and promotes normal differentiation in VHL-mutant renal cell carcinoma. Nagaprashantha LD; Vatsyayan R; Singhal J; Lelsani P; Prokai L; Awasthi S; Singhal SS Carcinogenesis; 2011 Apr; 32(4):568-75. PubMed ID: 21304051 [TBL] [Abstract][Full Text] [Related]
4. 2'-Hydroxyflavanone effectively targets RLIP76-mediated drug transport and regulates critical signaling networks in breast cancer. Nagaprashantha LD; Singhal J; Li H; Warden C; Liu X; Horne D; Awasthi S; Salgia R; Singhal SS Oncotarget; 2018 Apr; 9(26):18053-18068. PubMed ID: 29719590 [TBL] [Abstract][Full Text] [Related]
5. Topical 2'-Hydroxyflavanone for Cutaneous Melanoma. Bose C; Singh SP; Igid H; Green WC; Singhal SS; Lee J; Palade PT; Rajan A; Ball S; Tonk V; Hindle A; Tarbox M; Awasthi S Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31615091 [TBL] [Abstract][Full Text] [Related]
6. Anticancer activity of 2'-hydroxyflavanone towards lung cancer. Awasthi S; Singhal SS; Singhal J; Nagaprashantha L; Li H; Yuan YC; Liu Z; Berz D; Igid H; Green WC; Tijani L; Tonk V; Rajan A; Awasthi Y; Singh SP Oncotarget; 2018 Nov; 9(90):36202-36219. PubMed ID: 30546837 [TBL] [Abstract][Full Text] [Related]
7. Synergistic efficacy of RLIP inhibition and 2'-hydroxyflavanone against DMBA-induced mammary carcinogenesis in SENCAR mice. Singhal SS; Horne D; Singhal J; Vonderfecht S; Salgia R; Awasthi S Mol Carcinog; 2019 Aug; 58(8):1438-1449. PubMed ID: 31006917 [TBL] [Abstract][Full Text] [Related]
8. Metastasis of breast tumor cells to brain is suppressed by targeting RLIP alone and in combination with 2'-Hydroxyflavanone. Singhal J; Singhal P; Horne D; Salgia R; Awasthi S; Singhal SS Cancer Lett; 2018 Dec; 438():144-153. PubMed ID: 30223070 [TBL] [Abstract][Full Text] [Related]
11. Sperm-associated antigen 9 (SPAG9) promotes the survival and tumor growth of triple-negative breast cancer cells. Jagadish N; Gupta N; Agarwal S; Parashar D; Sharma A; Fatima R; Topno AP; Kumar V; Suri A Tumour Biol; 2016 Oct; 37(10):13101-13110. PubMed ID: 27449044 [TBL] [Abstract][Full Text] [Related]
12. 2'-hydroxyflavanone inhibits prostate tumor growth through inactivation of AKT/STAT3 signaling and induction of cell apoptosis. Wu K; Ning Z; Zhou J; Wang B; Fan J; Zhu J; Gao Y; Wang X; Hsieh JT; He D Oncol Rep; 2014 Jul; 32(1):131-8. PubMed ID: 24859932 [TBL] [Abstract][Full Text] [Related]
13. Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat. Tate CR; Rhodes LV; Segar HC; Driver JL; Pounder FN; Burow ME; Collins-Burow BM Breast Cancer Res; 2012 May; 14(3):R79. PubMed ID: 22613095 [TBL] [Abstract][Full Text] [Related]
14. 2'-Hydroxyflavanone induced changes in the proteomic profile of breast cancer cells. Nagaprashantha LD; Singhal J; Chikara S; Gugiu G; Horne D; Awasthi S; Salgia R; Singhal SS J Proteomics; 2019 Feb; 192():233-245. PubMed ID: 30248461 [TBL] [Abstract][Full Text] [Related]
15. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin. Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639 [TBL] [Abstract][Full Text] [Related]
16. Analysis of 2'-hydroxyflavanone (2HF) in mouse whole blood by HPLC-MS/MS for the determination of pharmacokinetic parameters. Gervazoni LFO; Gonçalves-Ozorio G; Ferreira-Paes T; Silva ACA; Silveira GPE; Pereira HM; Pinto DP; Cunha-Junior EF; Almeida-Amaral EE Front Chem; 2023; 11():1016193. PubMed ID: 36970405 [TBL] [Abstract][Full Text] [Related]
17. Spica prunellae promotes cancer cell apoptosis, inhibits cell proliferation and tumor angiogenesis in a mouse model of colorectal cancer via suppression of stat3 pathway. Lin W; Zheng L; Zhuang Q; Zhao J; Cao Z; Zeng J; Lin S; Xu W; Peng J BMC Complement Altern Med; 2013 Jun; 13():144. PubMed ID: 23800091 [TBL] [Abstract][Full Text] [Related]
18. Sunitinib significantly suppresses the proliferation, migration, apoptosis resistance, tumor angiogenesis and growth of triple-negative breast cancers but increases breast cancer stem cells. Chinchar E; Makey KL; Gibson J; Chen F; Cole SA; Megason GC; Vijayakumar S; Miele L; Gu JW Vasc Cell; 2014; 6():12. PubMed ID: 24914410 [TBL] [Abstract][Full Text] [Related]
19. Dillenia suffruticosa dichloromethane root extract induced apoptosis towards MDA-MB-231 triple-negative breast cancer cells. Foo JB; Saiful Yazan L; Tor YS; Wibowo A; Ismail N; Armania N; Cheah YK; Abdullah R J Ethnopharmacol; 2016 Jul; 187():195-204. PubMed ID: 27131434 [TBL] [Abstract][Full Text] [Related]
20. 1,3-Bis(3,5-dichlorophenyl) urea compound 'COH-SR4' inhibits proliferation and activates apoptosis in melanoma. Singhal SS; Figarola J; Singhal J; Leake K; Nagaprashantha L; Lincoln C; Gabriel Gugiu B; Horne D; Jove R; Awasthi S; Rahbar S Biochem Pharmacol; 2012 Dec; 84(11):1419-27. PubMed ID: 22959823 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]